Travis Whitfill is an academic researcher, venture capitalist, and entrepreneur in healthcare and biopharma. He is an Associate Research Scientist in the Departments of Pediatrics and Emergency Medicine at Yale University and focuses on health policy and health systems in pediatrics and emergency care. He has co-founded several biotech and healthcare startups companies, including Azitra Inc., which is a clinical-stage biotechnology company that is using living medicines to treat skin diseases. Travis is a Partner at Bios Partners, a healthcare-focused venture capital fund based in the United States that has approximately $130 million USD assets under management. He serves on the board of several companies, including Incysus Therapeutics Inc., 410 Medical Inc., Azitra Inc., and Immusoft Corporation (observer), as well as the International Network for Simulation-based Pediatric Innovation, Research and Education (INSPIRE). Mr. Whitfill received degrees from Yale University (MPH) and Dallas Baptist University (BS in biology), and is currently working on his PhD in health policy and economics at University College London.